SCHEMBL13234527

SCHEMBL13234527

CCOc1cc(COOC)nc2ccc(OC)cc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 7/20 0.43
▸ SMN1; SMN2 Q16637 4/20 0.43
▸ MEN1 O00255 3/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ KCNH2 Q12809 3/20 0.41
▸ CTSG P08311 1/20 0.41
▸ KLK7 P49862 1/20 0.41
▸ KLK14 Q9P0G3 1/20 0.41
▸ KLK5 Q9Y337 1/20 0.41
▸ ALDH1A1 P00352 4/20 0.39
▸ HPGD P15428 4/20 0.39
▸ MAPT P10636 3/20 0.39
▸ LMNA P02545 3/20 0.39
▸ GAA P10253 2/20 0.39
▸ TP53 P04637 1/20 0.39
▸ HTR1A P08908 1/20 0.39
▸ ADRA1D P25100 1/20 0.39
▸ ADRA1A P35348 1/20 0.39
▸ ADRA1B P35368 1/20 0.39
▸ HSD17B10 Q99714 5/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13234908 0.92 KDM4E (0.43) KDM4ESMN1; SMN2MEN1KMT2AKCNH2
SCHEMBL3025700 0.88 KDM4E (0.47) KDM4ESMN1; SMN2MEN1KMT2AKCNH2
SCHEMBL13214422 0.86 KDM4E (0.47) KDM4ESMN1; SMN2MEN1KMT2AKCNH2
SCHEMBL3022280 0.84 KCNH2 (0.46) KDM4ESMN1; SMN2MEN1KMT2AKCNH2
SCHEMBL13235536 0.83 KDM4E (0.39) KDM4ESMN1; SMN2MEN1KMT2AKCNH2
SCHEMBL3025917 0.81 KCNH2 (0.48) KDM4ESMN1; SMN2MEN1KMT2AKCNH2
SCHEMBL13234529 0.73 KCNH2 (0.51) KDM4ESMN1; SMN2MEN1KMT2AKCNH2
SCHEMBL31587770 0.71 KDM4E (0.56) KDM4ESMN1; SMN2MEN1KMT2AALDH1A1
Hydrochloric Acid SCHEMBL19211139 0.71 KDM4E (0.52) KDM4ESMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL19249249 0.71 PLA2G2A (0.46) KDM4ESMN1; SMN2MEN1KMT2AKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100196476-A1 PROCESS FOR THE PREPARATION AND PHARMACEUTICAL FORMULATIONS FOR 4-QUINOLINONES AND QUINOLINES AND USE THEREOF FUNDACAO UNIVERSIDADE FEDERAL DE SAO CARLOS (BR) 2010-08-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100196476-A1 PROCESS FOR THE PREPARATION AND PHARMACEUTICAL FORMULATIONS FOR 4-QUINOLINONES AND QUINOLINES AND USE THEREOF PF4, KCNQ1, KCNQ2 KDM4E 599/4885SMN1; SMN2 2941/4885MEN1 1964/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback